犬糖尿病个性化血糖管理研究

张 力本, 庞 敏*, 周 承福
南充职业技术学院现代农业技术学院

摘要


犬糖尿病患病率逐年上升，患犬需终身依赖外源性胰岛素，但传统标准化治疗存在显著的个体反应差异。本
文从病因分型（胰岛素缺乏型与抵抗型）、新型胰岛素制剂（长效类似物及超长效重组胰岛素）、辅助替代疗法（干细
胞、FGF-21衍生物、植物提取物）、合并症干预（犬尿氨酸通路及甲状腺功能减退）及个体化监测技术（血清果糖胺
（sFA）与连续血糖监测（CGM））等维度，系统综述犬糖尿病个性化血糖管理的研究进展，为临床实践提供参考。

关键词


犬糖尿病；个性化治疗；血糖监测；胰岛素类似物；合并症管理

全文:

PDF


参考


[1]Heeley A M, Brodbelt D C, O'Neill D G, et al.

Assessment of glucocorticoid and antibiotic exposure as

risk factors for diabetes mellitus in selected dog breeds

attending UK primary‐care clinics[J]. Veterinary Record,

2023,192(10):e2785.

[2]Shiel R E, Mooney C T. Correction to: Insulins for

the long term management of diabetes mellitus in dogs: a

review[J]. Canine Medicine and Genetics, 2022,9(1):1-2.

[3]O'Kell A L, Davison L J. Etiology and Pathophysiology

of Diabetes Mellitus in Dogs[J]. The Veterinary clinics of North

America. Small animal practice, 2023,53(3):493.

[4]Kuzi S, Tovi M M, Ahmad W A, et al. Clinical utility

of serum fructosamine in long‐term monitoring of diabetes

mellitus in dogs[J]. Veterinary Record, 2022,192(2):e2236.

[5]Zeugswetter F K, Beer R, Schwendenwein I.

Evaluation of fructosamine concentration as an index marker

for glycaemic control in diabetic dogs[J]. Veterinary Record,

2022,190(2):e244.

[6]张琼，刘洋，许楚楚，等.犬糖尿病酮症酸中毒

合并甲状腺功能减退[J].畜牧与兽医，2022，54（3）：

106-110.

[7]Denyer A L, Massey J P, Davison L J, et al. Dog

leucocyte antigen (DLA) class II haplotypes and risk of canine

diabetes mellitus in specific dog breeds[J]. Canine Medicine

and Genetics, 2020,7(1):15.

[8]Hulsebosch S E, Pires J, Bannasch M J, et al.

Ultra‐long‐acting recombinant insulin for the treatment of

diabetes mellitus in dogs[J]. Journal of Veterinary Internal

Medicine, 2022,36(4):1211-1219.

[9]Carzoli A, Meikle A, Pessina P. Canine obesity,

overweight, and adipokine serum concentration are

associated with hematological, biochemical, hormonal,

and cardiovascular markers[J]. Open Veterinary Journal,

2025,15(2):619-629.

[10]Bertalan A V, Drobatz K J, Hess R S. Effects of

treatment with lispro and neutral protamine Hagedorn

insulins on serum fructosamine and postprandial blood glucose

concentrations in dogs with clinically well-controlled diabetes

mellitus and postprandial hyperglycemia[J]. American Journal

of Veterinary Research, 2020,81(2):153-158.

[11]Mori A, Sako T, Lee P, et al. Comparison of timeaction profiles of insulin Glargine and NPH insulin in normal

and diabetic dogs[J]. Veterinary Research Communications,

2008,32(7):563-573.

[12]Oda H, Mori A, Ishii S, et al. Time-action profiles

of insulin degludec in healthy dogs and its effects on glycemic

control in diabetic dogs[J]. Journal of Veterinary Medical

Science, 2018,80(11):1720-1723.

[13]包喜军，李玲，秦海斌，等.脂肪干细胞的研

究现状及其在犬病诊疗上的应用前景[J].畜牧与兽医，

2022，54（5）：139-145.

[14]谭宁，李巴仑，韩苗，等.米托蒽醌甲磺酸盐预

处理脂肪间充质干细胞对犬糖尿病的治疗效果评价[J].畜

牧兽医学报，2024，55（3）：1328-1344.

[15]杜佳欣，李巴仑，寇正，等.血清饥饿法在间充

质干细胞治疗犬糖尿病中的应用（英文）[J].农业生物技

术学报，2024，32（12）：2773-2785.

[16]郭云鹏，牛顿，李爽，等.利用1型糖尿病小鼠

模型分析犬成纤维生长因子21的长效降糖效果[J].畜牧

兽医学报，2024，55（2）：770-784.

[17]Num-Adom S M, Adamu S, Aluwong T, et

al. Ethanolic extract of Anogeissus leiocarpus ameliorates

hyperglycaemia, hepato-renal damage, deranged electrolytes

and acid-base balance in alloxan-induced diabetes in dogs[J].

Scientific African, 2022,16:e01183.

[18]孔学礼，吴礼平，郝春燕，等.犬甲状腺机能

减退并发糖尿病的中西医结合诊疗[J].动物医学进展，

2020，41（3）：136-139.

[19]马晓婕，高嘉良，杨庭，等.犬尿氨酸途径与2

型糖尿病相关性研究进展[J].生命的化学，2024，44（8）：

1442-1448.


Refbacks

  • 当前没有refback。